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Epithelial and fibroblast cells were differentially susceptible to transformation by oncogenic src, ras, mos, raf, rac, and
cdc42 and the influence of adenovirus E1A. In contrast to NIH 3T3 cells, which are easily transformed by all the oncogenes
tested, epithelial cells were more resistant to transformation by the same oncogenes. Transformation efficiency of both
primary and immortal epithelial cells by E1B, V12ras, v-src, v-raf, and v-mos was increased by cotransfection of E1A 12S,
which enables these cells to overcome the M1/M2 mortality blocks, which are not present in NIH 3T3 cells. NIH 3T3 cell
transformation by these oncogenes was not altered by E1A. Although V12cdc42 or V12rac1 alone could produce foci on NIH
3T3 cells, morphological conversion was observed only in the presence of a hypertransforming E1A mutant and not WT E1A.
Epithelial cells were not transformed by V12cdc42 or V12rac1, even in the presence of WT or mutant E1A, but could be
transformed by coexpression of mos/raf and rac/cdc42, and the resultant phenotype was affected by the E1A C-terminus.
Hypertransformation, which has previously been reported with ras and E1A C-terminal mutants, turns out to be due to a
synergy with rac/cdc42, but not ERK/MAPK or PI3K ras effectors. Like V12rac, expression of the E1A hypertransforming
mutant resulted in the upregulation of vinculin and VASP, concomitant with the altered organization of the actin cytoskeleton
in these cells. The results show that in addition to requiring abrogation of M1/M2 mortality blocks, primary epithelial cells
require activation of the ERK MAPK cascade and rearrangement of the actin CSK to achieve transformation. In addition, the
E1A C-terminus regulates rac/cdc42 function in both epithelial and fibroblast cells to affect the extent of transformation
progression. © 2000 Academic Press
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Oncogenesis is a complex, multistep process that
involves alteration of both cell morphologies and growth
controls. In support of this, cellular transformation, al-
though cell type dependent, usually requires the coop-
eration of multiple dominant oncogenes and/or tumor
suppressor genes [reviewed in Hunter (1997)]. A large
number of such dominant oncogenes have been discov-
ered and characterized through the use of the NIH 3T3
cell system. Indeed, NIH 3T3 cells have proven to be
quite sensitive to transformation by dominant oncogenes
such as an activated ras. However, despite the fact that
greater than 80% human solid tumors are of epithelial
origin, and that tumors containing mutant ras genes are
mostly of epithelial origin, the majority of the substantial
data gathered on the actions and mechanisms of such
dominant oncogenes has been observed in immortal
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404fibroblast cells (Bokoch and Der, 1993). Previous data
suggest that there may be differences in the signals
required for transformation of fibroblasts versus epithe-
lial cells (Cowley et al., 1994; Mansour et al., 1994; Old-
ham et al., 1996). In addition, some proteins unique to
epithelial cells have been shown to be targets for the
action of dominant oncogenes such as Ha-ras, v-mos,
and v-src (Birchmeier et al., 1996). Comparative studies
may be able to address how transformation require-
ments and signals differ between fibroblasts and epithe-
lial cells.
The adenovirus (Ad) E1A region encodes an immortal-
izing gene product that cannot transform on its own, but
can enable some dominant oncogenes, such as ras,
polyoma middle T, v-src, or Ad E1B, to transform primary
epithelial cells [for review, see Bayley and Mymryk
(1994)]. The E1A region encodes two major genes, the
13S and 12S transcripts that are translated into the
289-aa and 243-aa nuclear phosphoproteins, respec-
tively. Each is able to induce quiescent cells into the cell
cycle. Most of these activities genetically correlate with
the ability of the 13S and 12S encoded proteins to bind to
a number of cellular proteins [reviewed in Bayley and
Mymryk (1994); Nevins (1995)], including pRb and related
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405E1A AND rac INTERACTIONS IN TRANSFORMATIONproteins (Egan et al., 1989; Whyte et al., 1989), p300 and
the CREB binding protein (CBP) (Arany et al., 1995; Whyte
t al., 1989), p27 (Mal et al., 1996), and cyclins A and E
with p33 cdk2 (Faha et al., 1993). The expression of the
13S or 12S encoded protein alone enables primary cells
to overcome both the M1 and the M2 mortality blocks
(Gopalakrishnan et al., 1997; Quinlan and Douglas, 1992;
Shay et al., 1991), leading to the immortalization of pri-
mary rodent cells. However, while the 243-aa protein is
able to immortalize both epithelial cells and fibroblasts,
the 289-aa protein can immortalize only fibroblasts (Kup-
puswamy and Chinnadurai, 1988), suggesting the possi-
bility of cell type-specific roles for these oncoproteins. In
further support of this idea, the 12S encoded protein
immortalizes primary epithelial cells such that they main-
tain their differentiated state (Fischer and Quinlan,
1998a; Quinlan, 1989; Quinlan and Grodzicker, 1987).
Finally, in addition to its role as a tumor virus oncogene,
E1A can function to suppress transformation, tumorige-
nicity, and metastatic potential when coexpressed with
certain other dominant oncogenes such as ras and
c-erbB2/neu [reviewed in Mymryk (1996)]. Thus, E1A may
exhibit differential effects on cell growth and transforma-
tion, depending on the cell type and oncogene(s) being
expressed in each cell type.
To understand the mechanism of potentiation by E1A
on oncogene and cell type transformation, we compared
the relative focus-forming ability and observable, mor-
phological transformation of NIH 3T3 fibroblasts; an im-
mortal, “normal,” epithelial kidney cell line (NRK 52E); as
well as primary kidney epithelial (BRK) cells, with known
oncogenes, plus and minus wild-type (WT) and mutant
E1A. As previously demonstrated, NIH 3T3 cells were
readily transformed by several dominant oncogenes act-
ing alone. However, both the primary and the immortal
epithelial cells exhibited decreased sensitivity to trans-
formation by T24/V12ras, v-raf, v-mos, v-src, and V12rac1,
or V12cdc42. Efficient transformation of epithelial cells
required activation of both the extracellularly regulated
kinase (ERK)/mitogen-activated protein kinase (MAPK)
cascade and a member of the Rho family of GTPases.
Except in the case of V12rac1 or V12cdc42, this de-
creased sensitivity was abrogated, to varying extents, by
E1A 12S, but not due to an effect on ERKs. These data
demonstrate that in contrast to fibroblasts, which can be
transformed by the activation of either the MAPK path-
way or the rearrangement of the actin CSK, epithelial
cells required both alterations, in addition to overcoming
mortality blocks by E1A. Hypertransformation by E1A
C-terminal mutants was restricted to V12ras. The E1A
mutants did not affect the ERK or PI3K ras effectors, but
rather synergized with rac or cdc42, but not rho. Neither
the efficiency nor the extent of transformation of NIH 3T3
cells by v-src, V12ras, v-mos, or v-raf was affected by 12S.
While the efficiency of focus formation was unaltered,
morphological transformation of NIH 3T3 cells byV12rac1 or V12cdc42 was observed only with an E1A
hypertransforming mutant and not WT12S. Thus, a func-
tional relationship between the E1A 12S C-terminus and
rac/cdc42 was evidenced in both fibroblasts and epithe-
lial cells.
RESULTS
C-terminal mutants of Ad5 E1A 12S enhance the
transformed phenotype of primary and established
epithelial cells cotransformed by V12ras, but not by
Ad E1B or v-src, or of NIH 3T3 cells
In general, primary epithelial cells cannot be trans-
formed by the expression of a single activated oncogene
(Tables 1 and 2). It has been demonstrated by many
groups that for some oncogenes, coexpression of the
immortalizing gene E1A of adenovirus can facilitate this
process (Tables 1 and 2) [for review see Bayley and
Mymryk (1994)]. The coexpression of V12/T24ras and
wild-type 12S (WT12S) results in the benign transforma-
tion of primary epithelial cells. Mutations in the second
TABLE 1
Transformation of Epithelial and Fibroblastic Cells by Dominant
Oncogenes and the Influence of E1A
NIH 3T3 NRK52E 19 BRK
FF MTx FF MTx FF MTx
T24ras 11 1 11 2 2 /
1WT12S 11 1 11 2 11 2
1HBdl12 11 1 11 1 111 1
v-src 11 1 1/2 1 1/2 1
1WT12S 11 1 11 1 11 1
1HBdl12 111 1 11 1 111 1
-mos 1 1 2 / 2 /
1WT12S 11 1 2 / 1/2 2
1HBdl12 11 1 11 2 1 2
v-raf 11 1 1/2 2 2 /
1WT12S 11 1 1/2 2 1/2 /
1HBdl12 11 1 1/2 2 1/2 /
12Rac1 11 2 2 / 2 /
1WT12S 11 2 2 2 2 /
1HBdl12 11 1 1/2 2 2 /
12Cdc42 1 2 2 / 2 /
1WT12S 1 2 2 / 2 /
1HBdl12 11 1 1/2 2 2 /
Note. Transfections with plasmids expressing the indicated onco-
enes were performed as described under Materials and Methods.
ata are representative of at least two experiments. FF, focus forma-
ion, was assayed at 2–3 weeks posttransfection, prior to the obser-
ance of G418r colonies in neo-vector control transfections on cell lines
nd from 2–4 weeks on primary cells. 2, no foci ever detected; 1/2,
–5 foci per dish consistently observed; 1, 6–20 foci; 11, 20 or more
oci. Mtx, morphologic transformation, compared to starting morphol-
gy. 1, morphology differed from starting cell; 2, no significant change;
, no stable cell lines were obtained to analyze.exon, which encodes the C-terminus of 12S, result in
transformation progression and metastasis of primary
l406 FISCHER AND QUINLANcells in the presence of V12ras (Boyd et al., 1993; Doug-
as et al., 1991; Jelsma et al., 1989; Linder et al., 1992;
Subramanian et al., 1989), which in vitro, we refer to as
hypertransformation (HTx). Primary epithelial cells trans-
formed by T24ras and several second-exon, HTx mutants
[used here are two point mutants, XS2 and XS3, and one
deletion mutant, HBdl12 (Douglas et al., 1991)] were
much smaller and had higher growth rates and satura-
tion densities than cells transformed by WT 12S and ras
(Figs. 1A, 1C, and 1D). In contrast, most mutations in the
second exon give rise to 12S genes that are no longer
even able to cooperate with Ad E1B (Douglas and Quin-
lan, 1995; Subramanian et al., 1991), despite the fact they
can hypertransform with ras. But even the few C-terminal
mutants that can cotransform with E1B (XS2, XS3,
HBdl12) do not alter the resultant transformed pheno-
type, when compared to WT12S (Fig. 1B; and data not
shown) (Douglas et al., 1991). If anything, the C-terminal
mutants provide less growth potential than WT12S in the
presence of E1B.
V-src has been previously shown to be able to coop-
erate with v-myc (MacAuley and Pawson, 1988) or E1A
(Fischer and Quinlan, 1998b) in transforming primary
epithelial cells. Transformation of primary BRK cells with
v-src and 12S does not require the C-terminus of E1A, but
is also not subject to modulation by mutations in that
region (Table 1 and Fig. 3) (Fischer and Quinlan, 1998b).
These data demonstrate that although E1A 12S can fa-
cilitate the v-src transformation of epithelial cells, it does
not alter the resultant src-transformed phenotype ob-
served. Thus, E1A 12S can enable src, ras, and E1B to
efficiently transform primary epithelial cells. However,
the ability of the E1A second exon to affect the resultant
transformed phenotype seems to be restricted to certain
dominant oncogenes, such as ras (and see below).
If immortalized epithelial cells, such as NRK 52E cells,
were transfected with V12ras, transformed foci were ob-
tained without E1A, unlike the primary epithelial cells
(Table 1). However, the enhanced transformation pheno-
type was again observed in the presence of HBdl12 but
not WT12S, resembling the primary epithelial cells (Table
TABLE 2
Soft Agar Growth of Transfected Primary Epithelial Cellsa
— T24ras v-src v-raf
vrac 1
v-raf V12rac1 V12cdc42
WT12S 2 1 1 2 1 nc nc
HBdl12 2 1 1 1 1 nc nc
— nc 1 nc nc nc nc
Note. 1, colonies obtained; 2, no colonies detected; nc, no stable
cell lines obtained.
a Cells were inoculated at 104, 105, and 106 per 60-mm dish.1 and Fig. 2). Somewhat surprisingly, the morphologies of
transformed NRK52E cells expressing V12ras alone orwith WT12S were similar, suggesting the possibility that
the C-terminal mutant HBdl12 exhibited a gain-of-func-
tion, not loss-of-function (suppression), phenotype. The
response of NRK52E cells to v-src resembled that of
primary epithelial cells, in that E1A facilitated transfor-
mation, and the presence or absence of the C-terminal
hypertransforming region did not affect the outcome (Ta-
ble 1 and Fig. 3). Of course, the well-established fibro-
blast cell line NIH 3T3 was efficiently transformed with
V12ras or v-src. The presence of WT or mutated 12S had
no obvious effects on the efficiency or extent of transfor-
mation of NIH 3T3 cells by ras or src (Table 1 and Figs.
2 and 3). Therefore, modulation of transformation by E1A
12S seems specific to functions/signals provided by an
activated ras oncogene and to epithelial cells, not fibro-
blasts.
The 12S C-terminus does not regulate MAPK or
phosphatidylinositol 3-kinase expression or activity
Differences in the levels of expression of E1A or ras
are not factors in determining the extent of the trans-
formed phenotype. Of course, the level of expression of
ras protein was substantially higher in primary epithelial
cells transfected with the V12ras oncogene than in E1B
transfected cells (that express only the endogenous c-
ras), but there were no significant differences among the
cells receiving WT or mutated 12S (Fig. 4A). Since ras
has many effectors (Joneson and Bar-Sagi, 1997; Mar-
shall, 1996; Wittinghofer, 1998), the observed phenotypic
differences among cells transformed by T24/V12ras and
WT or mutated 12S could be due to differential effects of
WT or mutated 12S on one or more ras effectors. Ras via
raf activates the ERK/MAPK cascade, which is necessary
for ras transformation and growth of NIH 3T3 cells (Cow-
ley et al., 1994; Khosravi-Far et al., 1995). The contribution
of ERK-type MAP kinase activation to the benign and
hypertransformation phenotypes was therefore analyzed.
As shown in Figs. 4B and 4D, no significant differences
were observed in the levels of expression of ERK1 and
ERK2, respectively, among ras or E1B transfected pri-
mary epithelial cells, regardless of whether they received
WT12S or HBdl12. Using an immune complex kinase
assay, with myelin basic protein as the in vitro substrate,
the levels of ERK1 and ERK2 activity were assayed. The
activity of either ERK1 or ERK2 was greater in those cells
that had received T24ras than in those that had received
E1B (Figs. 4C and 4E). This was to be expected, since
oncogenic ras constitutively activates the ERK/MAPK
cascade, while there is no evidence that E1B does so.
Nonetheless, similar levels of ERK1 and ERK2 activity
were detected among cells expressing WT12S or
HBdl12, within each group. Thus, there was no correla-
tion between ERK activity and the growth properties of
the transformed lines. These observations suggest that
differential activation of the ERK/MAPK pathway is not
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served in primary or established epithelial cells in the
presence of second-exon mutants of E1A 12S.
Activation of ras also directly induces the activity of phos-
phatidylinositol 3-kinase (PI3K) (Hu et al., 1995; Rodriguez-
iciana et al., 1997), which can be inhibited by wortmannin
FIG. 1. E1A 12S C-terminal mutants increase growth rates and satu
Growth of ras cotransformed cell lines in culture. (B) Growth of E1B cotr
and assayed as described under Materials and Methods. Each time p
clones. The error bars represent the standard error of the means. (C) Fl
(bottom) are smaller than WT12S1V12ras cells (top). Cells were tr
photographed at 103 magnification.Ui et al., 1995). The effect of wortmannin on cellular DNA
ynthesis was evaluated to determine whether PI3K sensi-tivity differences could account for the different transformed
states. WT12S1ras and HBdl121ras transformed epithelial
ells were incubated with increasing concentrations of
ortmannin and [3H]thymidine for 24 h, and the levels of
[3H]thymidine incorporation were determined. As a positive
control for wortmannin inhibition, NIH 3T3 cells were
densities of ras, but not E1B transformed primary epithelial cells. (A)
ed cell lines in culture. Cells from six independent clones were grown
averaged from quadruplicate counts that were averages from the six
metric data of the indicated cells are shown. (D) HBdl121V12ras cells
ed into single-cell suspensions, placed on a hemacytometer, andration
ansform
oint is
ow cytostarved for 24 h and then stimulated with EGF. While in-
creasing concentrations of wortmannin inhibited EGF-stim-
only in
.
408 FISCHER AND QUINLANulated DNA synthesis in NIH 3T3 cells (Klippel et al., 1996),
no such effect was observed in BRK cells transformed by
V12ras and WT12S or HBdl12 (Fig. 5). The above data
suggest that the observed differences among ras trans-
formed epithelial cells are not due to differential effects of
WT or mutant 12S on the two ras effectors PI3K and ERK.
Additional signals supplied by ras must be involved (see
below).
Constitutive activation of the ERK/MAPK cascade by
v-mos or v-raf is not sufficient for epithelial cell
transformation, but can be modestly assisted by 12S
Since 12S had little effect on the ERKs, we sought to
ascertain whether other ERK-pathway activators were af-
fected by 12S. v-mos and v-raf are serine–threonine protein
kinase encoding oncogenes capable of stimulating the
ERK-dependent kinase cascade. NIH 3T3 cells can be
readily transformed by either v-mos or v-raf, such that they
are able to form metastatic tumors in nude mice (Egan et
al., 1987). As expected, either v-mos or v-raf was effective in
transforming NIH 3T3 cells (Table 1), which exhibited an
altered, spindle-like morphology typical of such trans-
FIG. 2. Morphological alteration of Ha-ras transformants is observed
transformed cell lines, taken at equal magnification. Bar equals 30 mmformed cells (data not shown). Coexpression of WT12S or
HBdl12 did not alter the transformation competence ofthese oncogenes in NIH 3T3 cells (Table 1; and data not
shown). In the case of v-raf, primary epithelial cells exhib-
ited no focus formation and immortal epithelial cells exhib-
ited weak focus formation, which WT12S or HBdl12 was
only minimally able to improve (Table 1 and Fig. 6). Both
primary and established epithelial cells were also resistant
to v-mos transformation (Table 1, FF). While WT12S pro-
vided a minimal increase in v-mos foci, HBdl12 was more
effective in producing transformed foci with v-mos on both
primary and immortal epithelial cells (Table 1). Perhaps
v-mos stimulates more than ERKs to transform cells. How-
ever, no evidence of HTx by HBdl12 was observed with
either v-raf or v-mos (Table 1, Fig. 6; and data not shown).
These data indicate that in contrast to fibroblasts, epithelial
cells cannot be efficiently transformed by activators of ERK
cascades, such as v-mos or v-raf. E1A only minimally in-
creases foci production and no HTx was observed. This is
consistent with the lack of an effect of E1A on ERK1 and
ERK2 (see above).
Modulation of ras transformation by the 12S C-
terminus is at the level of rac or cdc42 function
epithelial cells with C-terminal E1A mutants. Photomicrographs of rasThe constituent pathways required for ras transforma-
tion of immortal fibroblasts have been shown to include
y E1A 1
409E1A AND rac INTERACTIONS IN TRANSFORMATIONnot only the ERK/MAP kinase cascade and PI3K, but also
a network of small GTPase proteins in the Rho family
(Nimnual et al., 1998; Van Aelst and D’Souza-Schorey,
1997). Rho family members have focus-forming ability on
their own on NIH 3T3 cells (Khosravi-Far et al., 1995; Qui
et al., 1995). These GTP binding proteins, which include
rho, rac, and cdc42, are involved in cell morphological
changes via induction of actin cytoskeletal rearrange-
ments [reviewed in Hall (1998)]. We have demonstrated
that V12ras HTx is not a consequence of the E1A 12S
C-terminus affecting ERKs or PI3K (see above). As ob-
served, the HBdl121ras hypertransformed BRK cells
have a dramatically different morphology, compared to
WT12S1ras transformed cells, suggesting the possibility
that the Rho GTPases could be the responsible ras
effectors. The endogenous levels of these proteins are
very low and not affected by the presence of WT or
HBdl12 (data not shown). Dominant negative (DN) forms
of the rho family GTP binding proteins have been shown
to inhibit ras transformation of fibroblasts, cell cycle
progression, and growth factor stimulated cytoskeleton
rearrangement (Van Aelst and D’Souza-Schorey, 1997).
To ascertain whether ras hypertransformation could be
FIG. 3. The morphology of v-src transformed cells is not affected b
magnification. Bar equals 30 mm.suppressed by DN GTPases, the DN version of rac,
N17rac, was added to WT12S1ras or HBdl121ras cells.Coexpression of N17rac had little effect on WT12S1ras
cells (Figs. 7 and 8), consistent with the possibility that
rac was already suppressed in these cells. Conversely,
N17rac had dramatic effects on HBdl121ras cells (Figs.
7 and 8). The HBdl121ras1N17rac cells exhibited an
altered, flattened morphology, decreased growth rates
and saturation density, and increased adhesion, resem-
bling WT12S1ras cells. Thus, hypertransformation in
HBdl121ras cells was suppressed by N17rac. These
observations are consistent with the possibility that there
was rac activity susceptible to downregulation by DNrac
in HBdl121ras cells.
To test whether the expression of constitutively acti-
vated rac (V12rac) could alter the observed transformed
phenotypes, primary BRK cells were transfected with
WT12S plus V12ras or HBdl12 plus V12ras, with and
without constitutively activated rac (V12rac). The addition
of V12rac to HBdl121ras cells had no detectable conse-
quences. That is, HBdl121V12ras1V12rac cells resem-
bled HBdl121V12ras cells in that they were both hyper-
transformed. This was evident in the numbers of foci, cell
morphology (Fig. 7), and growth properties (Fig. 8). On
the other hand, the expression of V12rac with
2S. Photomicrographs of v-src transformed cell lines, taken at equalWT12S1V12ras recapitulated the hypertransformed phe-
notype. The WT12S1V12ras1V12rac cells had a mor-
p
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HBdl121ras1V12rac) cells (Fig. 7). They exhibited in-
creased growth rates and saturation densities and de-
creased adhesion, resembling HTx cells (Fig. 8). Similar
results were observed with cdc42, but not with rho (data
not shown). These data suggest that WT12S interferes
with rac (or cdc42) activation by oncogenic ras, which
can be overcome by constitutively activated rac (or
cdc42), and the C-terminal mutant does not. Alternatively,
the HBdl12 mutant has gained the ability to enhance rac
function, consistent with what was observed in V12ras
transformation of NRK52E cells.
Alterations in the actin cytoskeleton in response to
mutant rac or E1A
Since rac is known to affect the actin cytoskeleton, the
filamentous actin structures of these cells were observed
via phalloidin stain, followed by epifluorescence micros-
copy. Epithelial cells exhibit a cortical actin filament net-
work and stress fibers, both of which are retained by cells
FIG. 4. The ERK cascade is upregulated in V12ras transformed
rimary epithelial cells, but is not affected by WT or mutant E1A. (A)
xpression of p21ras. The indicated cells were labeled overnight (to
teady-state equilibrium) with 200 mCi/dish [35S]methionine and then
immunoprecipitated with ras. (B and D) Erk expression. The indicated
cells were treated as in (A), but were immunoprecipitated with erk1- (B)
or erk2- (D) specific antibodies. (C and E) Erk activity. Erk1 (C) and erk2
(E) immune complex kinase assays were performed, using myelin
basic protein (MBP) as the substrate, from cells derived from the
indicated transfections, as described under Materials and Methods.
Phosphorylated MBP is shown and runs as a doublet on 15% gels with
a 1:25 cross-linking ratio.immortalized by WT12S (Fischer and Quinlan, 1998a;
Fischer et al., 1998). In WT12S1V12ras transformed epithe-lial cells, cortical actin was maintained; however, stress
fibers and focal adhesions were lost and small filopodial
and lamellipodial extensions were observed (Fig. 7, middle
left). In HBdl121V12ras hypertransformed epithelial cells
(Fig. 7, middle right), the actin cytoskeleton was disorga-
nized, and there was a dramatic increase in filopodial and
lamellipodial extensions. These features are consistent
with the increased motility of these hypertransformed cells.
The addition of V12rac to HBdl121V12ras cells did not
further alter the actin cytoskeleton (compare Fig. 7, top right
with middle right), consistent with the above data on growth
and adhesion. However, the addition of V12rac to
WT12S1ras cells (Fig. 7, top left), resulted in actin organi-
zation and distributions similar to those in the HBdl121ras
FIG. 5. Ras hypertransformation is not reflected in differential PI3K
sensitivity. (A) Expression of the p110 PI3K. P110 was immunoprecipi-
tated from the cell lines indicated, which had been labeled to steady
state, as described in the legend to Fig. 4. Comp. peptide, PI3K-specific
peptide was used; Non-comp. peptide, unrelated peptide was used. (B)
Effect of wortmannin inhibition of PI3K on cellular DNA synthesis. Cells
were incubated with increasing concentrations of wortmannin, indi-
cated on the X-axis, for 24 h and [3H]thymidine incorporation was
determined. NIH 3T3 cells were starved for 24 h and then incubated
with EGF (100 ng/ml) to stimulate PI3K-induced DNA synthesis. Cpm
were normalized to no-drug control for each cell line. Black bars,
HBdl121V12ras; stippled bars, WT12S1ras; gray bars, EGF-stimulated
NIH 3T3 cells. Numbers shown are averages of duplicate wells in
duplicate experiments.
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411E1A AND rac INTERACTIONS IN TRANSFORMATIONcells (Fig. 7, middle right) (and HBdl121ras1V12rac; Fig. 7,
op right). This is consistent with the hypothesis that the
1A C-terminus may affect the rac pathway. Conversely, the
-actin organization in epithelial cells expressing
T12S1ras1N17rac (Fig. 7, bottom left) was not unlike that
n cells expressing WT12S1ras; that is, N17rac had little
ffect on actin in WT12S1ras cells. On the contrary, the
xpression of N17rac in HBdl121ras cells (Fig. 7, bottom
ight), brought about significant actin reorganization, al-
hough not completely. These data suggest that the ob-
FIG. 6. Transformation of primary epithelial cells requires activation
modulate the efficiency and extent of transformation. Primary BRK cells
stained with Giemsa at 3 weeks after transfection.
FIG. 7. V12rac can induce hypertransformation of WT12S1ras cells
columns represent WT12S1ras transformed cells, while the two right co
V12rac1 (top) or N17rac (bottom). (Right) Cells were stained with phalloidin–FIT
Matching phase-contrast photomicrographs. Pictures were taken at equal maerved differences between epithelial cells transformed by
as plus WT12S or HBdl12 were due to differential effects of
he E1A C-terminus on the GTPases rac/cdc42.
ASP and vinculin are upregulated in the presence of
ypertransforming mutants of 12S or rac
The vasodilator-stimulated phosphoprotein (VASP) is
n adapter protein implicated in the regulation of actin
ynamics, including motility [reviewed in Holt et al.
ERK and Rho GTPase pathways in the presence of E1A, which can
ransfected with the indicated expression plasmids and then fixed and
7rac can suppress hypertransformation of HBdl121ras cells. Two left
are HBdl121ras transformed cells. Each cell type was transfected withof theand N1
lumnsC, visualized via epifluorescence microscopy, and photographed. (Left)
gnification. Bar equals 30 mm.
ls. Cell
412 FISCHER AND QUINLAN(1998)]. It couples signal transduction pathways to actin
polymerization. Overproduction of VASP has been impli-
cated in tumor progression (Liu et al., 1999). VASP is a
binding intermediate between vinculin and profilin. Vin-
culin is a component of cell–cell and focal adhesion
complexes, where actin attaches to the membrane [re-
viewed in Jockusch and Rudiger (1996)], and is itself an
adapter protein. Profilin is an actin monomer binding
protein involved in actin filament assembly [reviewed in
Weber (1999)]. We saw that vinculin, VASP, and profilin
were specifically upregulated in the presence of V12rac,
but not V12ras, in epithelial cells expressing WT12S (Fig.
9A; and data not shown). The level of a control protein,
grp94, a chaperone, was not so affected. Reflecting the
loss of focal adhesions, vinculin was decreased in
WT12S1V12ras cells, compared to WT12S1WTras cells.
However, we saw that in all situations examined, vinculin
was upregulated in mutant, compared to WT E1A-ex-
pressing cells (Fig. 9B). While VASP was not upregulated
in the presence of V12ras, with WT12S (WT12S1V12ras
cells), it was dramatically increased in HBdl121V12ras-
expressing cells (Fig. 9B), similar to what was observed
when V12rac was added to the WT12S1V12ras cells.
The changes in VASP and vinculin expression correlate
well with the above observations on cell morphology and
F-actin organization in the different cells. While actin
organization was drastically different among the various
cell types, the level of actin per se was unaltered (Fig.
9B). Thus, HBdl12 affected the organization of F-actin and
similar actin regulators as V12rac did.
Activated Rac1 or Cdc42 cannot transform epithelial
cells, even in the presence of E1A
FIG. 8. The growth rates, saturation densities, and adhesion of epi
altered by the expression of V12rac or N17rac, respectively. (A, B) Gr
HBdl121V12ras transformed BRK cells. Cells from six independent clon
time point is averaged from quadruplicate counts, which were average
of WT12S1V12ras (left) or HBdl121V12ras (right) transformed BRK cel
harvested, as described under Materials and Methods.We have observed a functional interaction between
rac and cdc42 and 12S in the extent of ras transfor-mation of BRK cells (see above). To test whether focus-
forming activity by rac or cdc42 could be observed on
epithelial cells, NRK 52E and primary BRK cells were
transfected with plasmids expressing V12cdc42 or
V12rac and compared to similar transfections on NIH
3T3 cells. While relatively efficient focus-forming ac-
tivity of either V12rac1 or V12cdc42 was observed on
NIH 3T3 cells, no foci were obtained on either the
primary or the established epithelial cells (Tables 1
and 2 and Fig. 10). Cotransfection of either WT12S or
HBdl12 with V12cdc42 or V12rac1 resulted in only a
minimal increase of foci in NRK52E cells, but had no
effect on BRK cells (Table 1, FF, Table 2, and Figs. 6
ells transformed with V12ras and WT12S or HBdl12 are differentially
urves of V12rac and N17rac derivatives of (A) WT12S1V12ras or (B)
grown and assayed as described under Materials and Methods. Each
the six clones. (C) Relative adhesion of V12rac and N17rac derivatives
s were allowed to grow on plastic for 2 days, to near confluence, and
FIG. 9. Regulators of actin dynamics are upregulated in the presence
of V12rac or HBdl12. The indicated cell lines were analyzed for the
expression of vinculin (Vi), VASP (Va), Grp94 (G), or actin (A) by immu-thelial c
owth c
es were
s fromnoblotting equal protein concentrations of total cell lysates with anti-
bodies specific to each antigen.
413E1A AND rac INTERACTIONS IN TRANSFORMATIONand 10). The efficiency of transformation by these two
oncogenes was not affected by WT or mutant 12S in
NIH 3T3 cells (Table 1). These results suggest a dif-
ference among the cell types in susceptibility to trans-
formation by the rho family GTPases alone. Activation
of either the ERK pathway or rho family members
enables transformation of fibroblasts, but not epithe-
lial cells, even in the presence of E1A. Thus, E1A
cannot facilitate epithelial transformation by all domi-
nant oncogenes.
While NIH 3T3 cells can be transformed by either
pathway, epithelial cell transformation requires
activation of both the ERK and the Rho pathways
In contrast, to NIH 3T3 fibroblasts, constitutive activa-
tion of the Rho family or ERK pathway was unable to
transform epithelial cells. However, cotransfection of ei-
ther v-raf or v-mos with V12cdc42 or V12rac1 resulted in
efficient focus formation of the established epithelial cell
line NRK 52E (data not shown), but still not of primary
epithelial cells (Table 2). In terms of foci numbers, co-
transfections of v-mos or v-raf with V12cdc42 or V12rac1
were not significantly different than any one oncogene
alone on NIH 3T3 cells. For primary epithelial cells, such
cotransfections were able to give rise to transformed foci
that could grow in soft agar only in conjunction with E1A
FIG. 10. Epithelial cells cannot be efficiently transformed by activated
Cdc42 or Rac1, in contrast to NIH 3T3 cells. NIH 3T3 or NRK52E cells
were transfected with either a neomycin-resistance vector only (neo) or
the same vector expressing either V12rac or V12cdc42 (top two rows).
BRK cells were transfected with the V12rac or V12cdc42 plasmids alone
(bottom middle and right) or in combination with WT or mutant E1A.
HBdl121V12Cdc42 is shown at bottom left; other combinations simi-
larly yielded no foci (not shown). Dishes were stained 3 weeks post-
transfection.expression (Table 2, Fig. 10; and data not shown). When
WT12S was transfected with both v-raf and V12rac1, afew foci were obtained (Table 2 and Fig. 6). The resulting
cell lines did not have significantly enhanced growth
properties and resembled WT12S1ras cells (data not
shown). However, when both activated V12rac1 and v-raf
were transfected with HBdl12, a marked increase in
transformation efficiency was observed (Table 2 and Fig.
6). The resultant foci gave rise to cell lines that were very
similar in growth behavior and morphology to the hyper-
transformed HBdl121ras cells (data not shown). Thus, in
contrast to fibroblasts, which can be transformed by
either ERK stimulation or rho family activation, epithelial
cells require the cooperative effects of constitutive ERK
stimulation and rho family activation. Primary epithelial
cells require functions provided by E1A as well. Further-
more, E1A hypertransforming mutants seem to be able to
synergize with rac1 and cdc42 to bring about a more
aggressively transformed state.
Although V12rac and V12cdc42 alone can transform
NIH 3T3 cells, coexpression of HBdl12 can affect
their morphology
In contrast to observations with T24ras, v-src, v-mos,
or v-raf (Table 1; and data not shown), no significant
changes in morphology were observed in the V12rac1 or
V12cdc42 transformed NIH 3T3 cells (Table 1, MTx, and
Fig. 11). Surprisingly, cotransfection of these rho family
genes with HBdl12, but not WT12S, resulted in dramatic
morphological transformation of NIH 3T3 cells (Table 1,
MTx, and Fig. 11). No comparable effect was observed
when HBdl12 was coexpressed with the other onco-
genes tested on NIH 3T3 cells (Table 1 and Figs. 2 and
3; and data not shown). The HBdl121V12cdc42 trans-
formed NIH 3T3 cells were round and adhered poorly to
substrate. The HBdl121V12rac transformed NIH 3T3
cells exhibited a spindle-shaped morphology. However,
expression of HBdl12 alone in NIH 3T3 cells did not
produce foci or altered cell morphology (Fig. 11). Again, a
synergy between HBdl12 and rac/cdc42 was observed,
but for the first time an effect was detected in fibroblasts.
For the epithelial cells (primary or established), no trans-
formed foci were obtained unless an ERK activator, such
as v-raf or v-mos, and E1A were included (see above).
Morphology changes could therefore be evaluated only
in the context of three oncogenes. Under those condi-
tions, HBdl12, but not WT12S, effected morphological
transformation by also synergizing with rac/cdc42. From
the studies conducted here it seems that the original
hypertransformation observed with ras is probably via
rac/cdc42. These data also suggest that while NIH 3T3
cells are more susceptible to transformation by activa-
tion of rho-related proteins than epithelial cells are,
HBdl12 seems to be able to synergize with rac/cdc42 to
affect the properties of the transformed cells, regardless
of the cell type.
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414 FISCHER AND QUINLANDISCUSSION
We have compared the effects of various oncogenes in
he transformation of mesenchymally and epithelially de-
ived cell types. In contrast to NIH 3T3 fibroblasts, the
pithelial cells, both primary and immortal, were resis-
ant to transformation by the dominant oncogenes v-src,
-mos, v-raf, V12rac1, and V12cdc42. Activation of the
otent ERK cascade, via v-mos, v-raf, or v-src, was insuf-
ient for epithelial transformation, but could be potenti-
ted, to varying extents, by coexpression of 12S. Cotrans-
ection of 12S did not enable transformation of epithelial
ells by the Rho family GTPases, which regulate the actin
ytoskeleton. Of the oncogenes examined, only V12ras
as able to transform both immortal epithelial cells and
ibroblasts. This is probably because ras has many ef-
ectors (Joneson and Bar-Sagi, 1997; Marshall, 1996; Wit-
inghofer, 1998). That ERK stimulation was inadequate for
pithelial cell transformation suggested that an ERK-
ndependent pathway(s) of T24/V12ras was also re-
uired. This additional ras function turned out to be a
ho GTPase, since coexpression of V12rac or V12cdc42
ith v-mos or v-raf did effect epithelial cell transforma-
ion. Thus, unlike fibroblasts, which can be transformed
y activation of either the ERK or the Rho pathway,
pithelial cells require activation of both pathways. This
esult indicates that additional constraints are present on
pithelial cell growth, which is significant because
reater than 80% of human tumors are of epithelial origin.
Five regions of E1A12S are required to overcome the
1 and M2 mortality blocks leading to primary epithelial
ell immortalization (Gopalakrishnan et al., 1997; Quinlan
nd Douglas, 1992). Expression of the N-terminal half of
1A, encoded by exon 1, overrides the M1 block. This
FIG. 11. Morphologic alteration of V12cdc42 or V12rac1 transformed N
with GTPase alone or with WT E1A or HBdl12 and compared to E1
establishment of transformed cell lines, representative lines were pho
30 mm.egion encompasses the two pRB family binding do-
ains of E1A (Egan et al., 1989; Whyte et al., 1989), whichbrogate p21 and p16 cell cycle inhibition, leading to cell
ycle progression. Their expression is required for all
ncogenes that E1A facilitates. The pRB interacting re-
ions are all that are required for v-src (Fischer and
uinlan, 1998b). Ras requires an additional E1A region,
he N-terminal, p300/CBP binding domain (Egan et al.,
989; Whyte et al., 1989). Coexpression of the C-termi-
us, encoded by exon 2, abrogates the M2 block and is
ecessary for E1B transformation. This is still inadequate
o cotransform primary epithelial cells with V12rac1 or
12cdc42 and only minimally potentiates v-raf or v-mos.
rimary epithelial cells require coexpression of v-mos or
-raf and V12rac1 or V12cdc42, as well as E1A.
In addition to being able to potentiate cell transforma-
ion by various dominant oncogenes, E1A can impact
ellular transformation by modulating the resultant trans-
ormed phenotype. We and others have suggested that
ecause C-terminal mutants of E1A allow hypertransfor-
ation and tumor progression in the presence of V12ras,
T12S suppresses or downmodulates ras transforma-
ion (Boyd et al., 1993; Douglas et al., 1991; Jelsma et al.,
1989; Linder et al., 1992; Subramanian et al., 1989; see
also Mymryk, 1996). The ability of activated ras to stim-
ulate multiple types of effectors and signaling pathways
has been the subject of intense scientific attention and
has yielded numerous key insights into the growth, mo-
tility, and oncogenic transformation of mammalian cells
[reviewed in Joneson and Bar-Sagi (1997); Marshall
(1996); Wittinghofer (1998)]. Several results described
herein suggest a functional relationship between the
E1A C-terminus and the rac/cdc42 GTPases that can
affect the extent of transformation progression. Although
12S could somewhat facilitate transformation by consti-
cells in the presence of HBdl12. NIH 3T3 cells were transfected either
transfected cells (HBdl12 shown) or vector control (neo). Following
ed. Photomicrographs were taken at equal magnification. Bar equalsIH 3T3
A onlytutive activation of the ERK MAPK pathway, ERK1 and
ERK2 were not differentially affected by the presence of
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415E1A AND rac INTERACTIONS IN TRANSFORMATIONWT or mutant 12S. Epithelial cells were not efficiently
transformed by rho GTPases, and alone E1A could not
bring about their transformation. However, BRK cells
expressing v-raf or v-mos and V12rac1 or V12cdc42 were
greatly affected by whether WT12S or HBdl12 was
present. The addition of HBdl12 gives rise to rounded,
hypertransformed cells and WT12S to flat, epithelial-look-
ing cells, resembling cells obtained with activated T24/
V12ras, respectively (Douglas et al., 1991; Fischer et al.,
998). The addition of V12rac1 or V12cdc42 to
T12S1ras cells caused a hypertransformed phenotype
n BRK cells, but had no effect on the already hyper-
ransformed HBdl121ras cells. The coexpression of
17rac in HBdl121ras hypertransformed cells was sup-
ressive, but not so in WT12S1ras benignly transformed
ells. These data suggest that WT12S suppressed
nd/or HBdl12 stimulated or synergized with rac/cdc42
ctivation by V12ras. NIH 3T3 cells did not require any
2S functions to yield transformants with any of the
ncogenes evaluated. With the exception of V12rac and
12cdc42, coexpression of 12S did not seem to affect the
esultant transformed phenotype. Unlike the other onco-
enes tested, no morphological changes were observed
n NIH 3T3 cells transfected with V12rac/cdc42 alone or
ith WT12S. Surprisingly, cotransfection of HBdl12 with
12rac/cdc42 did effect morphological transformation,
gain demonstrating a synergy between HBdl12 and
hese two GTPases. Thus, it seems that activities spe-
ific to the rho family of GTPases are affected by the
-terminus of 12S to regulate the extent of transforma-
ion, in fibroblasts and epithelial cells.
Tumor progression is intimately linked to the loss of
ifferentiation or epithelial–mesenchymal transitions
EMT), which result in the generation of metastatic car-
inoma cells [reviewed in Birchmeier et al. (1996); Hay
(1995)]. We have previously demonstrated that the C-
terminus of E1A 12S can regulate EMT (Fischer and
Quinlan, 1998a). Immortalization of primary epithelial
cells by WT12S gives rise to immortalized cells that
maintain epithelial differentiation characteristics (Quin-
lan, 1995; Quinlan and Douglas, 1992; Quinlan et al.,
1988), including maintenance of actin structures, which
are targets of rho GTPases, and cell–cell adhesion junc-
tional complexes, even after many passages in culture
and even in the presence of activated ras (Fischer and
Quinlan, 1998a,c). Loss of cell–cell adhesion leads to
invasion and metastasis [reviewed in Birchmeier et al.
(1995)]. HBdl12 immortalization of primary epithelial cells
results in cells that have lost many differentiated prop-
erties, including some actin structures and cell–cell ad-
hesion, predisposing them to more aggressively trans-
formed cells upon the addition of V12ras. Rho family
members, which regulate actin structure formation (Hall,
1998), also have the ability to affect differentiation, in-
cluding adhesion, tumor progression, and even metas-
tasis (del Peso et al., 1997; Fischer and Quinlan, 1998c;Quinlan, 1999). The results described in this paper sug-
gest a functional relationship between the E1A C-termi-
nus and the rho GTPases. Thus, it seems possible that
the 12S C-terminus could mediate its differentiation/tu-
mor progression effects through rac/cdc42 activation
and/or function.
Although it has been assumed, by us and others, that
the E1A C-terminal mutants have lost a suppressive
function, several observations made here are inconsis-
tent with that model. HTx with ras was observed not just
with deletion, but also with point mutants of 12S (XS2 and
XS3). Examination of the effects on NRK52E cells dem-
onstrated that the presence or absence of WT12S did not
affect ras transformation. On the other hand, the pres-
ence of the HTx mutant HBdl12 did affect ras transfor-
mation. If WT12S was suppressive, we would have ex-
pected to have seen that the phenotypes of ras alone
and ras plus HBdl12 to be similar to each other, but
different and suppressed in the presence of WT12S. That
was not the case. In the V12rac and V12cdc42 transfec-
tions of NIH 3T3 cells, no morphological alterations were
observed, unlike with the other oncogenes tested on
these cells. The coexpression of WT12S did not alter this.
However, dramatic morphological changes were ob-
served in the presence of HBdl12. Together these data
seem to suggest that a mutated second exon of E1A can
produce a gain of function, rather than the loss of repres-
sion.
It is possible that first-exon functions are regulated by
second-exon encoded structures; however, this is not
observed at the level of E1A protein binding to pRB or
p300/CBP or cell cycle activation (Gopalakrishnan et al.,
1997). Furthermore, XS2, XS3, and HBdl12 are efficiently
localized to the nucleus like WT12S and are not less
stable (Douglas et al., 1991; Douglas and Quinlan, 1994,
1995). The ras transformation–modulation region encom-
passes the C-terminal 67 aa. The molecular mechanism
by which this C-terminal region affects tumor progres-
sion is not known. It may be mediated by interacting with
cellular transcriptional regulatory proteins, as has been
demonstrated for the growth regulating peptides en-
coded by exon 1. In contrast to the plethora of binding
partners for the N-terminus (Bayley and Mymryk, 1994;
Nevins, 1995), only a single cellular polypeptide, CtBP,
has been identified for the C-terminus of E1A. CtBP
interacts with the E1A C-terminus through a 5-aa motif
(PLDLS) located at aa 233–237 of the Ad5 12S protein
(Boyd et al., 1993; Molloy et al., 1998; Schaeper et al.,
1995, 1998), just upstream from the very C-terminal NLS
(aa 239–243). This domain represses CR-1-dependent
transactivation (Sollerbrant et al., 1996). CtBP complexes
with another cellular polypeptide, CtIP, which is dis-
rupted by peptides containing PLDLS (Schaeper et al.,
1998). CtBP homologues turn out to be transcriptional
corepressors involved in development (Nibu et al., 1998;
Poortinga et al., 1998; Turner and Crossley, 1998). Loss of
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416 FISCHER AND QUINLANinteraction of the C-terminal mutant proteins and CtBP
would be a satisfactory model. However, the hypertrans-
forming mutations used here were upstream of the CtBP
interacting domain: XS2 is A210N, XS3 is L227V, and the
aa deleted in HBdl12 are 192–209. It is, of course, pos-
sible that these mutations affect the conformation of the
CtBP binding site, preventing its interaction, while they
do not interfere with the functioning of the adjacent NLS.
However, CtBP does complex with HBdl12, while it does
not bind to a mutant missing aa 210–227 (HBdl23) or aa
228–237 (HBdl34; Douglas et al., 1991, and unpublished
observations). Interestingly, HBdl23 and HBdl34 are de-
fective in their nuclear localization, indicating that the
NLS is not recognized (Douglas and Quinlan, 1994). Al-
ternatively, there are additional, as yet unidentified, bind-
ing sites that are affected by the mutants analyzed here.
In general, the facile transformation of NIH 3T3 cells is
in contrast to that observed with epithelial cells. These
differences may reflect a cell type bias of the oncogenes
currently studied. However, it is clear that epithelial cells
have more proliferative blocks and additional restraints
on their behavior that must be overridden to enable
transformation, compared to fibroblasts. Consequently,
more tumor suppressors must be inactivated and/or
more proto-oncogenes must be activated to effect tumor-
igenesis of epithelial cells, as demonstrated herein. E1A
can complement ERK activators to transform, but does
not seem to affect ERKs or PI3K levels or activity to alter
the extent of transformation progression. On the other
hand, E1A cannot complement Rho GTPases to effect
epithelial cell transformation, but can influence rac/
cdc42 in fibroblasts and epithelial cells to alter the trans-
formed phenotype. Thus ras hypertransformation, as pre-
viously described, probably involves the GTPases rac
and cdc42 and the E1A C-terminus.
MATERIALS AND METHODS
Cells, plasmids, and transfection assays
Primary BRK cells were prepared from 5-day-old rats
(Fisher F344, Harlan, IN). They were maintained in
DMEM (BioWhittaker, Walkersville, MD) supplemented
with 100 u/ml penicillin, 100 mg/ml streptomycin, and 5%
fetal calf serum (BioWhittaker), unless otherwise noted.
Plasmids expressing either WT12S or C-terminal mu-
tants were previously described (Douglas et al., 1991), as
was the T24/V12ras plasmid (Taparowsky et al., 1982).
The v-src plasmid pJHv-src was a generous gift from Dr.
A. Reynolds (Vanderbilt University, Nashville, TN). pZ-
IPneo plasmids expressing V12cdc42 and V12rac1 were
obtained from Dr. Y. Zheng, (University of Tennessee,
Memphis, TN). v-mos plasmid (pM1) has been previously
characterized (Blaire et al., 1980). The v-raf plasmid used
was pF4, ATCC clone 45010. For convenient comparison,
all plasmids were used at 5 mg per 60-mm dish, exceptV12ras, which was used at 2 mg per 60-mm dish on all
hree cell types.
BRK cell transfections were performed at 2 days post-
lating using a modification of the calcium phosphate
recipitation technique. Transfections on NRK 52E and
IH 3T3 cells were done similarly, except that cells were
ransfected 24 h after plating at subconfluence, and then
t 24–48 h posttransfection cells were overlaid with se-
ection medium containing G418. Cells were fixed with
ethanol and Giemsa stained or cell lines were cloned
t approximately 3 weeks posttransfection, at which time
eo-resistance vector transfected controls were not yet
isible. Both clonal and nonclonal ($10 colonies) lines
ere established, as previously described (Khosravi-Far
t al., 1995). This was done to limit clonal bias of mor-
hologies and behaviors observed.
dhesion and growth assays
To determine cell growth rates and saturation densi-
ies, cells from six independent clones (for the activated
ominant oncogenes) or multiclonal populations from
hole, G418 selected plates (for dominant negative
ransfections) were seeded onto tissue culture plastic
Becton Dickinson, Bedford, MA) at either 104 or 105 cells
per 60-mm dish. Cells were then harvested as single-cell
suspensions with trypsin at 24-h intervals, and quadru-
plicate counts were obtained with a hemocytometer.
Results were averaged for the clones/plates counted. For
fluorescence activated cell sorting analysis, cells were
maintained in normal growth medium for 2 days prior to
analyses. A total of 106 cells were trypsinized, fixed with
ethanol, and stained with propidium iodide for process-
ing on a Coulter Profiler II analyzer (Coulter, Miami, FL).
Phoenix Flow Multicycle analysis software was used to
calculate percentage G1, percentage G2/M, and percent-
age S phases in each population, as well as coefficient
of variation. Results shown are representative of at least
two independent samples.
For determining relative adherence to substrate, cells
were grown on tissue culture plastic for 2 days, washed
in Ca21-, Mg21-free PBS twice, overlaid with 1 ml/dish
PBS, and placed on a rotary shaker for 5 min. Superna-
tant PBS was removed and gently vortexed, and the
plates were washed once with 1 ml PBS, counted as
described above, and added to the previous supernatant.
To determine the number of cells remaining attached,
dishes were then treated as described above with tryp-
sin/EDTA, and the remaining cells were counted. “Rela-
tive adhesion” was defined as the percentage of total
cells remaining attached per dish.
To test the ability of cell lines to grow independently of
solid substrate, 60-mm dishes were coated with 2 ml
medium containing 0.5% agar. The cells were then plated
onto these dishes in the same medium at plating densi-
ties of 104, 105, and 106 cells per plate. Plates were
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417E1A AND rac INTERACTIONS IN TRANSFORMATIONincubated as described for cell line maintenance, with
fresh medium (containing 0.5% agar) added every 3–4
days. Colony formation was assayed between 10 and 18
days after plating by overlaying the agar medium with 0.5
ml of p-iodonitrotetrazolium violet solution (0.5 g/liter in
sterile water). Colonies were observed 24 h later.
Immunofluorescence and photomicroscopy
Cells were seeded onto glass coverslips and main-
tained as described above. Cells were washed with
cytoskeleton buffer and then fixed with 1 or 3.7% para-
formaldehyde in PBS for 10 min at room temperature,
washed twice in cytoskeleton buffer, and permeabilized
in 0.5% Triton X-100 in PBS. Nonspecific binding was
blocked with 0.5% FCS/0.5% BSA. Cells were incubated
in 1 mg/ml phalloidin-FITC for 30 min in a humidified
chamber and washed three times with PBS. Photomicro-
graphs were taken with a Zeiss Axiophot epifluores-
cence microscope using a 35-mm Zeiss camera or an
Optronics DEI-750 video camera coupled to an Integral
Technologies Flashpoint 24-bit Frame Grabber Card. For
phase photomicroscopy, an Olympus CK2 microscope
fitted with a Minolta X-700 was used with Kodak Tri-X Pan
ASA 400 film.
Immunoprecipitations and Western blot analyses
For immunoprecipitation followed by Western blot
analysis, cells were labeled with approximately 10 mCi
35S-translabel methionine (ICN Pharmaceuticals, Inc.,
osta Mesa, CA) in 5 ml DMEM/FCS 10–12 h prior to
ysis. Cells were rinsed with PBS once and lysed in 1%
onidet-P40 (NP-40)/0.5% deoxycholate in 50 mM Tris,
H 7.6, 1 mM sodium vanadate, 5 mM phenylmethylsul-
onyl fluoride, on ice for 30 min. Lysates were then
craped into microcentrifuge tubes and centrifuged for
0 min at 4°C. The supernatant lysates were normalized
o each other by scintillation counting and brought to
qual volumes with lysis buffer. Immunoprecipitations
ere carried out at 4°C, with the indicated antibodies,
nd immune complexes were collected with 0.3% protein
–Sepharose CL-4B in lysis buffer. The immunoprecipi-
ation complexes were washed three times. The com-
lexes were then dried and resuspended in sample
uffer and boiled for 10 min, followed by sodium dodecyl
ulfate–polyacrylamide gel electrophoresis (SDS–PAGE)
esolution and Western blotting as described below.
For metabolically labeled immunoprecipitations, cells
ere starved of methionine in methionine-minus
MEM/PS for 30 min at 37°C, labeled with 150–200 mCi
35S-translabel methionine per milliliter in methionine-mi-
us DMEM/PS for 1–2 h, and lysed as described above
or immunoprecipitation/Western blot analyses. Samples
ere separated by SDS–PAGE resolution, which wasluorographed and subjected to autoradiography with
odak X-OMAT film.For Western blot analyses, approximately equal num-
ers of cells were labeled with (approximately 1 mCi/2 3
106 cells) trans-label methionine (ICN Pharmaceuticals
Inc.) overnight in DMEM with 5% FCS. Cells were
washed twice with PBS, lysed in boiling 23 sample
buffer (13 is 10% glycerol, 5% b-mercaptoethanol, 3%
DS, 62.5 mM Tris, pH 6.8, 0.02% bromophenol blue),
craped into tubes, and boiled for an additional 5 min.
ysates were passed through a 26-gauge needle three
imes and centrifuged for 5 min at 14,000g to remove
ebris. Lysates were normalized to each other by scin-
illation counting and separated by SDS–PAGE. Proteins
ere transferred to Immobilon-SP in a Bio-Rad Western
lot apparatus in CAPS transfer buffer. After transfer, the
ilters were incubated overnight in blocking buffer (0.7%
ish gelatin in TBST: 10 mM Tris, pH 7.5, 150 mM NaCl,
.1% Tween 20). Blots were probed with specified anti-
odies diluted in blocking buffer, followed by three
ashes with TBST. Antibodies were detected with anti-
ouse horseradish peroxidase conjugate (Sigma, St.
ouis, MO) diluted in blocking buffer, following by a
hemiluminescence detection method, utilizing oxidized
uminol to generate a photographic signal.
mmune complex kinase assays
Immune complex kinase assays were performed as
escribed. After immune complex collection (as de-
cribed for immunoprecipitations), complexes were
ashed twice in lysis buffer, washed once with high-salt
uffer (0.65 M NaCl, 0.25% gelatin, 0.5% NP-40, 5 mM
ris, pH 7.4), and then washed twice with reaction buffer
30 mM HEPES, pH 7.4, 10 mM MgCl2, 1 mM dithiothre-
itol, 20 mM ATP, 5 mM benzamidine). As in vitro sub-
strates, 2 mg/reaction of myelin basic protein was used
or ERK1 and 2 assays. The reactions were carried out at
0°C for 10 min. Phosphorylated proteins were analyzed
y SDS–PAGE on 15% gels followed by autoradiography.
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